The Food and Drug Administration (FDA) announced Friday that it has issued emergency use authorization (EUA) for Eli Lilly's new monoclonal antibody treatment. Clinical trials have shown the treatment ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback